Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S323000, C514S326000, C546S201000, C546S213000, C546S214000, C546S245000
Reexamination Certificate
active
07125895
ABSTRACT:
This invention relates to novel arylalkyl cyclic amine derivatives. This invention also relates to chemokine receptor antagonists that are be effective as therapeutic agents and/or preventive agents for diseases such as atherosclerosis, rheumatoid arthritis, transplant rejection, psoriasis, asthma, ulcerative colitis, glomerulonephritis, multiple sclerosis, pulmonary fibrosis, and myocarditis, in which tissue infiltration of blood monocytes and lymphocytes plays a major role in the initiation, progression or maintenance of the disease. Furthermore, chemokine receptor antagonists also inhibit the interaction of viruses, which attack blood monocytes and lymphocytes, through the use of a chemokine receptor. One such example is the HIV virus.
REFERENCES:
patent: 4895842 (1990-01-01), Okamoto et al.
patent: 5643946 (1997-07-01), Christensen, IV
patent: 217 286 (1987-04-01), None
patent: 417 698 (1991-03-01), None
patent: WO 97/26250 (1997-07-01), None
patent: WO 98/04554 (1998-02-01), None
patent: WO 98/50534 (1998-11-01), None
patent: WO 99/00121 (1999-01-01), None
patent: WO 99/25686 (1999-05-01), None
Flygare et al, Chemical Abstract vol. 131 No. 184944, Preparation of phenyl and aryl-fused thiazole derivatives as antiviral agents for suppression and treatment of herpes family viral infections and sexually-transmitted viral diseases. 1999.
Flygare et al., STN International, HCAPLUS Database, Columbus, OH, Accession No. 1999:549264, Reg. No. 240136-65-6 (2006).
Khalid et al., “N,N′-disubstituted L-isoglutamines as novel cancer chemotherapeutic agents,”Chemical Abstracts, 107(7):16, abstract # 107, originally published inDrugs Exp. Clin. Res.,13(1):57-60 (1987).
Moree Wilna
Tarby Christine M.
Bristol-Myers Squibb Pharma Research Labs, Inc.
Freistein Andrew B.
Saeed Kamal A.
VanAtten Mary K.
LandOfFree
Cyclic amine derivatives and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic amine derivatives and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amine derivatives and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3636763